Broadcast Live   |   Upload & Publish  | About  | Register  | Sign in
E-mail:
Password:
Remember me on this computer
You need to install or upgrade your Flash Player!

3B NEXUS video platform & portal supports the latest version of Macromedia Flash player.


3B PLAYER by 3B NEXUS

Close [ X ]
Copy this code to embed & stream this video on your website
 
Copy this URL to share or create a link back to this video
Scrip Roundtable Debate
Expert Panellists
United Kingdom
Adopting Orphans - A Call to Arms for Collaboration Part 5: Rare econometrics
Once orphan drugs have received regulatory approval, companies still have to clear a fourth hurdle: obtaining reimbursement from payers. But existing methodologies were not designed with rare diseases in mind, posing a new challenge for payers attempting to assess the cost-effectiveness of orphan drugs.

[ close ] 
Please select the appropriate option to comply with legal regulations

Individual Investor Professional Investor or Financial Advisor
This multimedia channel includes videos, webcasts and live broadcasts suitable for members of the general public over 18 years of age and not engaged in providing investment advice. Access this channel for personal interest & information only. This multimedia channel includes investor videos and webcast presentations, live broadcasts and documents intended only for authorised and regulated professionals and financial advisers eligible to provide investment advice to private investors.
I comply with these terms I comply with these terms
Remember my choice for all channels on this portal Enter Media Channel »
No reliance should be placed on the information on this site which may change without notice.
You should read the Terms & Conditions section before browsing this site.

Search in Sort By
<<   BACK   1 2 3 4 5 6 7 8 9 of 14   MORE   >> SHOW